P027 Dermatologic Surgery
DESCRIPTION
Speakers will present recent impactful publications and discuss advancements in the use of artificial intelligence in the field of dermatologic surgery. Developments in the management of melanoma, squamous cell carcinoma, and Merkel cell carcinoma will also be reviewed, including the use of gene-expression profiling, immunohistochemistry for melanoma, and circulating tumor-DNA for the surveillance of Merkel cell carcinoma. This session is directed to dermatologic surgeons and dermatologists who evaluate and manage patients with skin cancer, including high-risk tumors.
LEARNING OBJECTIVES
Describe the most impactful recent literature in dermatologic surgery and cutaneous oncology
Review the development of and advancements in using artificial intelligence in dermatologic surgery
Identify advances in the evaluation and management of melanoma, squamous cell carcinoma, and Merkel cell carcinoma
SCHEDULE
10:00 AM
Literature Review: In Case You Missed It
Martha Laurin Council, MD, MBA, FAAD
10:25 AM
AI in Dermatologic Surgery
Nahid Y Vidal, MD, FAAD
11:00 AM
Advances in Melanoma
Valencia D. Thomas, MD, FAAD
11:20 AM
Advances in Squamous Cell Carcinoma
Daniel Brian Eisen, MD, FAAD
11:35 AM
Advances in Merkel Cell Carcinoma
Lisa Zaba, MD, PhD, FAAD
DIRECTOR
Siegrid S. Yu, MD, FAAD
University of California, San Francisco
SPEAKERS
Martha Laurin Council, MD, MBA, FAAD
Division of Dermatology, Washington University
Daniel Brian Eisen, MD, FAAD
University of California, Davis
Valencia D. Thomas, MD, FAAD
MD Anderson Cancer Center
Nahid Y Vidal, MD, FAAD
Mayo Clinic
Lisa Zaba, MD, PhD, FAAD
DISCLOSURES
Martha Laurin Council, MD, MBA, FAAD
Castle Biosciences – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Sanofi/Regeneron – Advisory Board(Honoraria), Investigator(Grants/Research Funding);
Daniel Brian Eisen, MD, FAAD
No financial relationships exist with ineligible companies.
Valencia D. Thomas, MD, FAAD
Castle Biosciences, Inc – Advisory Board(Honoraria); Merk – Advisory Board(Honoraria); National Comprehensive Cancer Network – Speaker(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria);
Nahid Y Vidal, MD, FAAD
No financial relationships exist with ineligible companies.
Siegrid S. Yu, MD, FAAD
No financial relationships exist with ineligible companies.
Lisa Zaba, MD, PhD, FAAD
No financial relationships exist with ineligible companies.